Re:New Concerning Variant: B.1.1.529
by timr on Friday November 26, 2021 @06:17PM
(#29355309)
"Symptoms" are self-reported. Symptomatic seroprevalence is objective.
What this should tell you is that "symptoms" are a bad endpoint for a randomized-controlled trial, not that if the good endpoint doesn't show you what you want, you should rely on the bad one.
What this should tell you is that "symptoms" are a bad endpoint for a randomized-controlled trial, not that if the good endpoint doesn't show you what you want, you should rely on the bad one.